Bone Biologics Corp Stock Filter Stocks by Fundamentals
| BBLG Stock | USD 1.53 0.07 4.38% |
Bone Biologics Corp fundamentals help investors to digest information that contributes to Bone Biologics' financial success or failures. It also enables traders to predict the movement of Bone Stock. The fundamental analysis module provides a way to measure Bone Biologics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bone Biologics stock.
Bone | Shares Owned by Insiders |
Bone Biologics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Bone Biologics from analyzing Bone Biologics' financial statements. These drivers represent accounts that assess Bone Biologics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Bone Biologics' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 35.4M | 35.3M | 16.0M | 2.4M | 1.2M | 1.1M | |
| Enterprise Value | 46.7M | 47.1M | 9.3M | (5.1M) | (1.8M) | (1.7M) |
Bone Biologics Institutional Holders
Institutional Holdings refers to the ownership stake in Bone Biologics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bone Biologics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bone Biologics' value.| Shares | Citadel Advisors Llc | 2023-09-30 | 11.3 K | Tower Research Capital Llc | 2023-12-31 | 1.2 K | Wells Fargo & Co | 2023-12-31 | 4.0 | Kepos Capital Lp | 2023-09-30 | 0.0 | Warberg Asset Management Llc | 2023-09-30 | 0.0 | Geode Capital Management, Llc | 2023-12-31 | 0.0 | Mml Investors Services Inc | 2023-12-31 | 0.0 | Virtu Financial Llc | 2023-12-31 | 0.0 | Walleye Trading Advisors, Llc | 2023-12-31 | 0.0 | Ubs Group Ag | 2023-12-31 | 0.0 |
Bone Fundamentals
| Return On Equity | -2.02 | ||||
| Return On Asset | -0.96 | ||||
| Current Valuation | (2.17 M) | ||||
| Shares Outstanding | 879.18 K | ||||
| Shares Owned By Insiders | 8.15 % | ||||
| Shares Owned By Institutions | 1.26 % | ||||
| Number Of Shares Shorted | 15.11 K | ||||
| Price To Earning | (15.45) X | ||||
| Price To Book | 0.51 X | ||||
| EBITDA | (9.43 M) | ||||
| Net Income | (8.95 M) | ||||
| Cash And Equivalents | 5.45 M | ||||
| Cash Per Share | 0.53 X | ||||
| Total Debt | 12.77 M | ||||
| Current Ratio | 80.11 X | ||||
| Book Value Per Share | 5.44 X | ||||
| Cash Flow From Operations | (9.56 M) | ||||
| Short Ratio | 0.10 X | ||||
| Earnings Per Share | (34.01) X | ||||
| Target Price | 19.5 | ||||
| Beta | 0.58 | ||||
| Market Capitalization | 1.35 M | ||||
| Total Asset | 3.74 M | ||||
| Retained Earnings | (80.91 M) | ||||
| Working Capital | 2.91 M | ||||
| Current Asset | 1.07 M | ||||
| Current Liabilities | 2.16 M | ||||
| Net Asset | 3.74 M |
About Bone Biologics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bone Biologics Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bone Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bone Biologics Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Bone Biologics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bone Biologics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bone Biologics will appreciate offsetting losses from the drop in the long position's value.Moving against Bone Stock
| 0.87 | ELEV | Elevation Oncology Earnings Call Next Week | PairCorr |
| 0.85 | AGTI | Agiliti Financial Report 14th of May 2024 | PairCorr |
| 0.81 | DSGN | Design Therapeutics Financial Report 14th of May 2024 | PairCorr |
| 0.81 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
| 0.7 | NXL | Nexalin Technology | PairCorr |
The ability to find closely correlated positions to Bone Biologics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bone Biologics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bone Biologics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bone Biologics Corp to buy it.
The correlation of Bone Biologics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bone Biologics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bone Biologics Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bone Biologics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Bone Biologics Piotroski F Score and Bone Biologics Altman Z Score analysis. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Complementary Tools for Bone Stock analysis
When running Bone Biologics' price analysis, check to measure Bone Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bone Biologics is operating at the current time. Most of Bone Biologics' value examination focuses on studying past and present price action to predict the probability of Bone Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bone Biologics' price. Additionally, you may evaluate how the addition of Bone Biologics to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
Is Bone Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bone Biologics. If investors know Bone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bone Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (34.01) | Return On Assets (0.96) | Return On Equity (2.02) |
The market value of Bone Biologics Corp is measured differently than its book value, which is the value of Bone that is recorded on the company's balance sheet. Investors also form their own opinion of Bone Biologics' value that differs from its market value or its book value, called intrinsic value, which is Bone Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bone Biologics' market value can be influenced by many factors that don't directly affect Bone Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bone Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bone Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bone Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.